| Template section | Key items to extract | Primary evidence sources to query | Expected output fields | Notes on typical evidence type |
|---|---|---|---|---|
| 1. Disease information | Concise disease definition; whether “SOX10 neurocristopathy spectrum” is a formal disease label or umbrella term; accepted synonyms; cross-references to Waardenburg syndrome type 2E/4C and PCWH-related entities; whether data are disease-level or patient-level | OMIM, Orphanet, MONDO, MeSH, ICD-10/ICD-11, PubMed | OMIM/Orphanet/MONDO/MeSH/ICD IDs; preferred label; synonyms; classification notes | Disease database entries plus review articles |
| 2. Etiology | Causal role of germline SOX10 variants; loss-of-function vs dominant-negative mechanisms; genetic and non-genetic risk/protective factors; evidence for gene-environment interaction | OMIM, PubMed, ClinVar, ClinGen, gnomAD, CTD, guidelines | Causal gene(s); mechanism class; inheritance; modifier/risk factors; any protective factors | Case reports/series, variant curation, mechanistic studies |
| 3. Phenotypes | Hearing loss, pigmentary abnormalities, Hirschsprung disease, peripheral neuropathy, central dysmyelination/leukodystrophy, developmental delay, dysmorphism, ophthalmic findings; onset, severity, progression, frequency | HPO, OMIM, Orphanet, PubMed, DECIPHER | HPO terms; phenotype frequencies; age of onset; progression pattern; QoL impacts | Case series, natural history papers, reviews |
| 4. Genetic/molecular information | SOX10 gene/protein function; variant spectrum (missense, nonsense, frameshift, splice, deletions); recurrent variants; domain-specific effects; allele frequencies; somatic vs germline; modifier genes | ClinVar, ClinGen, OMIM, NCBI Gene, HGNC, Ensembl, UniProt, gnomAD, PubMed | HGNC ID; transcript/protein IDs; variant nomenclature; ACMG class; gnomAD AF; functional consequence | Variant databases, functional assays, genotype-phenotype studies |
| 5. Environmental information | Whether any environmental, lifestyle, or infectious contributors modify presentation or complications; largely expected to be limited/NA for a monogenic disorder | CTD, PubMed, CDC, WHO | Environmental exposures; lifestyle modifiers; infectious triggers/none reported | Usually sparse; reviews or negative evidence |
| 6. Mechanism / pathophysiology | Neural crest developmental defects; enteric nervous system development; melanocyte and Schwann/glial lineage effects; myelination defects; pathway context (e.g., neural crest transcriptional networks) | PubMed, Reactome, KEGG, GO, UniProt, Human Protein Atlas | GO biological processes; CL cell types; pathway names; upstream/downstream causal chain; tissue-level consequences | Functional studies, animal models, review synthesis |
| 7. Anatomical structures affected | Inner ear/cochlea, iris/retina/pigment system, colon/enteric nervous system, peripheral nerves, CNS white matter, skin/hair melanocyte-bearing tissues | Uberon, HPO, OMIM, Orphanet, PubMed, Human Protein Atlas | UBERON terms; CL terms; GO cellular component terms; laterality/localization notes | Clinical reports plus developmental biology studies |
| 8. Temporal development | Congenital or neonatal onset; childhood recognition; lifelong course; progression or stability of neurologic manifestations; critical windows for hearing and GI intervention | OMIM, Orphanet, PubMed, registries | Age-at-onset categories; course pattern; disease duration; progression descriptors | Natural history reports, case series |
| 9. Inheritance and population | Autosomal dominant inheritance; penetrance/variable expressivity; de novo rate; mosaicism; prevalence/incidence of SOX10-related entities; sex ratio; ancestry/geographic clustering | OMIM, Orphanet, ClinVar, gnomAD, PubMed, registries | Inheritance; penetrance notes; prevalence/incidence; demographic summaries; founder effects if any | Case aggregation studies, registries, reviews |
| 10. Diagnostics | Clinical recognition of syndromic hearing loss/pigment anomalies/aganglionosis; audiology, GI workup, neuroimaging, nerve studies; genetic testing strategy (single gene, panel, WES/WGS, CMA) | GeneReviews, GTR, OMIM, ClinVar, PubMed, clinical guidelines | Diagnostic criteria; recommended tests; differential diagnosis; biomarker/imaging findings; panel genes; test modalities | Guidelines, diagnostic reviews, laboratory practice papers |
| 11. Outcome / prognosis | Survival and morbidity driven mainly by Hirschsprung complications and neurologic severity; developmental and functional outcomes; prognostic effect of variant class and phenotype burden | PubMed, Orphanet, registries | Morbidity outcomes; complication rates; disability/QoL measures; prognostic factors | Natural history studies, follow-up case series |
| 12. Treatment | Standard Hirschsprung surgical management, hearing rehabilitation (hearing aids/cochlear implant where appropriate), developmental therapies, neuropathy support, multidisciplinary surveillance; any experimental therapies | Clinical guidelines, PubMed, ClinicalTrials.gov, GeneReviews | Treatment modalities; MAXO terms; outcomes; adverse effects; personalized management notes | Clinical management papers, reviews, limited trial evidence |
| 13. Prevention | Genetic counseling, cascade testing, prenatal/preimplantation testing, early detection of hearing and GI disease, tertiary prevention of complications | ACMG/NSGC guidance, GeneReviews, PubMed, GTR | Counseling recommendations; screening approaches; reproductive options; complication prevention measures | Guidelines and counseling literature |
| 14. Other species / natural disease | Whether naturally occurring SOX10-related disease is reported outside humans; comparative pathology of pigmentation/aganglionosis/myelination phenotypes | OMIA, PubMed, NCBI Taxonomy | Species; orthologous gene IDs; comparative phenotype notes | Veterinary genetics and comparative biology reports |
| 15. Model organisms | Mouse, zebrafish, iPSC, organoid or cell models of SOX10 deficiency or variant effects; fidelity to human pigmentation, ENS, and myelination phenotypes | MGI, ZFIN, Alliance of Genome Resources, PubMed, Cellosaurus | Model type; allele/model ID; recapitulated phenotypes; mechanistic readouts; limitations | Functional genomics, developmental biology, disease modeling studies |


*Table: This table organizes the SOX10 neurocristopathy spectrum report into the main template sections, highlighting what still needs to be extracted and which source types should supply the missing evidence. It is useful as a structured retrieval checklist when literature and database access are restored.*